Brown & Brown posted $1.7 billion in revenue, a 30.4% jump, while adjusted earnings per share came in at $1.07 versus a $1.09 consensus. The results boost momentum as the stock sits at $68.27, down 10.2% year‑to‑date but up 14.6% in the past month.

Key Highlights

  • Adjusted EBITDAC rose 27.0% to $598 million, with margin slipping to 35.7% from 36.7% a year earlier.
  • Diluted net income per share grew 7.7% to $0.84; adjusted EPS reached $1.07, falling short of consensus.
  • Income before taxes increased 23.2% to $383 million, while the pre‑tax margin fell to 22.9%.

Net income rose 24.7% to $288 million, and diluted EPS climbed 7.7% to $0.84. The insurer’s total assets expanded to $29.9 billion, with cash balances of $918 million. Management cited the strong top‑line growth as a platform for the pending RSC Topco acquisition and future market share gains.

Adjusted EBITDAC increased 27.0% to $598 million, yet the EBITDAC margin eased to 35.7% from 36.7% a year earlier. Income before taxes grew 23.2% to $383 million, while the pre‑tax margin slipped to 22.9% from 24.2% previously. Diluted net income per share rose 7.7% to $0.84, but the adjusted EPS of $1.07 fell short of market expectations.

The shortfall underscores pressure on profitability despite strong revenue expansion.

Revenue and Profit Mechanics

Total revenues climbed $391 million to $1.7 billion, driven primarily by commissions and fees that rose to $1,654 million. Organic revenue declined 0.7%, but the addition of contingents lifted organic revenue with contingents by 0.7% to $1,237 million. Net income attributable to the company increased $57 million to $288 million, reflecting higher underwriting profit and favorable expense trends.

The balance sheet showed cash of $918 million and fiduciary assets of $2.613 billion, positioning the firm for further acquisitions. These figures reveal a business model that can generate growth even as core organic lines contract, indicating resilience in a competitive insurance market. The stock’s 52‑week range sits between $53.81 and $104.10, highlighting significant upside potential.

Sector peers such as MRSH were little changed, AJG rose 0.7%, and RYAN remained flat, suggesting limited relative movement in the broader insurance space. The price dip, despite solid earnings, may present a buying opportunity for investors who view the earnings miss as temporary and value the company’s expanding asset base.

Upcoming RSC Topco Acquisition Deadline

The company’s growth narrative is closely tied to the anticipated closing of its pending acquisition of RSC Topco, Inc. slated for completion by year‑end 2026. Closing the deal would add scale to Brown & Brown’s underwriting platform and could enhance earnings per share in the subsequent quarters. Investors will watch for any guidance on the transaction’s timeline and related integration costs, which could materially affect future performance.

The ultimate impact will hinge on how smoothly the acquisition integrates and whether synergies materialize as projected.

Peers Moving on This News

  • Marsh & McLennan Companies Inc (MRSH) little changed
  • Arthur J. Gallagher & Co. (AJG) up 0.7%
  • Ryan Specialty Holdings Inc (RYAN) little changed

Analysis based on the Form 8-K filed 27 July 2026.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.